Epidemiology of carbapenem resistant Klebsiella pneumoniae colonization in an intensive care unit

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 8, 2012, Pages 1811-1817

  Debby, B D ^a   Ganor, O ^a   Yasmin, M ^a   David, L ^a   Nathan, K ^a   Ilana, T ^a   Dalit, S ^a   Smollan, G ^a   Galia, R ^a  

^a SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ERTAPENEM; IMIPENEM; MEROPENEM;

ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CATHETER INFECTION; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; ISRAEL; KLEBSIELLA PNEUMONIAE; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECTAL SWAB; RISK FACTOR; SCORING SYSTEM; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SMEAR; SURGERY; SURGICAL INFECTION; TERTIARY HEALTH CARE; VENTILATOR ASSOCIATED PNEUMONIA;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; CARBAPENEMS; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECTUM; RISK FACTORS;

EID: 84866378920     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1506-5     Document Type: Article

References (37)

1. Williams VR, Callery S, Vearncombe M, Simor AE (2009) The role of colonization pressure in nosocomial transmission of methicillin-resistant Staphylococcus aureus. Am J Infect Control 37:106-110
2. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C et al (1998) The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 158:1127-1132 (Pubitemid 28242318)
3. Merrer J, Santoli F, Appere de Vecchi C, Tran B, De Jonghe B, Outin H (2000) "Colonization pressure" and risk of acquisition of methicillin-resistant Staphylococcus aureus in a medical intensive care unit. Infect Control Hosp Epidemiol 21:718-723
4. Tacconelli E (2009) Antimicrobial use: risk driver of multidrug resistant microorganisms in healthcare settings. Curr Opin Infect Dis 22:352-358
5. Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC et al (2007) Risk factors for colonization with extended-spectrum beta-lactamase-producing bacteria and intensive care unit admission. Emerg Infect Dis 13:1144-1149 (Pubitemid 47359156)
6. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD et al (2001) Novel carbapenemhydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 45:1151-1161 (Pubitemid 32230996)
7. Bradford PA, Bratu S, Urban C, Visalli M, Mariano N, Landman D et al (2004) Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City. Clin Infect Dis 39:55-60 (Pubitemid 38879549)
8. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M et al (2005) Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med 165:1430-1435 (Pubitemid 40973427)
9. Maltezou HC, Giakkoupi P, Maragos A, Bolikas M, Raftopoulos V, Papahatzaki H et al (2009) Outbreak of infections due to KPC- 2-producing Klebsiella pneumoniae in a hospital in Crete (Greece). J Infect 58:213-219
10. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP (2008) Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 29:1099-1106
11. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y (2007) Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 51:3026-3029 (Pubitemid 47206254)
12. Navon-Venezia S, Leavitt A, Schwaber MJ, Rasheed JK, Srinivasan A, Patel JB et al (2009) First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States. Antimicrob Agents Chemother 53:818-820
13. Hussein K, Sprecher H, Mashiach T, Oren I, Kassis I, Finkelstein R (2009) Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns. Infect Control Hosp Epidemiol 30:666-671
14. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J (2007) Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 30:525-529 (Pubitemid 350064465)
15. Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, Shachar D et al (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31:620-626
16. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Yet al (2009) Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53:3365-3370
17. Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J et al (2009) Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 63:427-437
18. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y (2008) Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 52:1028-1033 (Pubitemid 351358384)
19. Borer A, Saidel-Odes L, Riesenberg K, Eskira S, Peled N, Nativ R et al (2009) Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia. Infect Control Hosp Epidemiol 30:972-976
20. Centers for Disease Control and Prevention (CDC) (2009) Guidance for control of infections with carbapenem-resistant or carbapenemaseproducing Enterobacteriaceae in acute care facilities. Morb Mortal Wkly Rep 58:256-260
21. Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373-383 (Pubitemid 17055592)
22. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-829 (Pubitemid 15250137)
23. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of theWorking Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 22:707- 710
24. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 36:309-332 (Pubitemid 351763841)
25. CLSI (2006) Performance standards for antimicrobial susceptibility testing. Sixteenth informational supplement (approved standard M100-S16). The Clinical Laboratory Standards Institute, Wayne, PA
26. HindiyehM, Smollen G, Grossman Z, Ram D, Davidson Y,Mileguir F et al (2008) Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol 46:2879-2883
27. Schwaber MJ, Carmeli Y (2008) Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA 300:2911-2913
28. Kochar S, Sheard T, Sharma R, Hui A, Tolentino E, Allen G et al (2009) Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae. Infect Control Hosp Epidemiol 30:447-452
29. Calfee D, Jenkins SG (2008) Use of active surveillance cultures to detect asymptomatic colonizationwith carbapenem-resistantKlebsiella pneumoniae in intensive care unit patients. Infect Control Hosp Epidemiol 29:966-968
30. Pavlov I (2007) High colonization pressure might compromise the efficiency of routine methicillin-resistant Staphylococcus aureus screening. Clin Infect Dis 44:766-767
31. Manzur A, Gavalda L, Ruiz de Gopegui E, Mariscal D, Dominguez MA, Perez JL et al (2008) Prevalence of methicillin-resistant Staphylococcus aureus and factors associated with colonization among residents in community long-term-care facilities in Spain. Clin Microbiol Infect 14:867-872
32. Tacconelli E, Cataldo MA, De Pascale G, Manno D, Spanu T, Cambieri A et al (2008) Prediction models to identify hospitalized patients at risk of being colonized or infected with multidrugresistant Acinetobacter baumannii calcoaceticus complex. J Antimicrob Chemother 62:1130-1137
33. Depuydt PO, Vandijck DM, Bekaert MA, Decruyenaere JM, Blot SI, Vogelaers DP et al (2008) Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilatorassociated- pneumonia. Crit Care 12:R142
34. Von Korff M, Wagner EH, Saunders K (1992) A chronic disease score from automated pharmacy data. J Clin Epidemiol 45:197-203
35. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS et al (2005) Utility of the chronic disease score and Charlson comorbidity index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 161:483-493 (Pubitemid 40315619)
36. Quach S, Hennessy DA, Faris P, Fong A, Quan H, Doig C (2009) A comparison between the APACHE II and Charlson index score for predicting hospital mortality in critically ill patients. BMC Health Serv Res 9:129
37. Combes A, Luyt CE, Fagon JY, Wolff M, Trouillet JL, Chastre J (2006) Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia. Intensive Care Med 32:1970-1978 (Pubitemid 44833110)